Picture of Glaukos logo

GKOS Glaukos Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Glaukos, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-49.6-99.2-135-146-188
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items37.343.749.284.8185
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.58-13.4-10.1-39.5-48
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities24.7-33.1-57.8-61.3-14.8
Capital Expenditures-47.8-30.3-20.2-6.3-24.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-10.47534.354.1-53.3
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-58.244.814.147.8-77.6
Financing Cash Flow Items8.98-2.43-3.27-6.86-8.13
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities39.36.251591.511.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.9616.5-27.375-79.7